Concepedia

Remi Okoye

RO

Statistics

Publications

5

Citations

230

H-Index

5

Active since

2011

Affiliations

UCB Pharma (United Kingdom)(Current)

UCB Pharma (Belgium)

Remi Okoye is an author at UCB Pharma (United Kingdom) specializing in immunology, cytokine biology, and inflammation.

Publications per year

2011–2020

5

Publications

5

Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling

Suzanne Cole, Janine Murray, Catherine Simpson et al. · Frontiers in Immunology · 2020 · 81 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

Massimo Marenzana, Kevin Greenslade, Alison Eddleston et al. · Arthritis & Rheumatism · 2011 · 74 citations

Medicine, Endocrinology, Immunology +17

Sclerostin Downregulation Globally by Naturally Occurring Genetic Variants, or Locally in Atherosclerotic Plaques, Does Not Associate With Cardiovascular Events in Humans

Gill Holdsworth, James R Staley, Peter Hall et al. · Journal of Bone and Mineral Research · 2020 · 32 citations · Full text

Medicine, Cardiology, Clinical Sciences +15

Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNFα in rheumatoid arthritis

Adrian Moore, Sarah Allden, Tim Bourne et al. · Journal of Translational Medicine · 2014 · 31 citations · Full text

Medicine, Immunology, Pharmacology +17

THU0038 Bimekizumab dual inhibition of IL-17A and IL-17F provides evidence of IL-17F contribution to chronic inflammation in disease-relevant cells

A. Maroof, Remi Okoye, Timothy Smallie et al. · Annals of the Rheumatic Diseases · 2017 · 12 citations · Full text

Life Sciences, Immunology, Clinical Immunology +16

1–5 of 5